Hey, everybody. I'm really happy that we have returned yesterday. Asha Latipova is a former

pharmaceutical R&D executive. She worked in the industry for 25 years and ultimately owned

managed several contract research organizations working on clinical trials for more than 60

pharmaceutical companies, including Pfizer, AstraZeneca, J&J, GSK, Novartis, and many others.

Latipova worked many years in cardiovascular safety assessments and interacted with the FDA

and other regulatory agencies on these matters on behalf of her clients as part of the FDA

cardiovascular safety research consortium. Sasha sold her companies and retired from the industry

before the pandemic. And Sasha has been speaking out on COVID and the mRNA vaccines and related

matters since early 2021 as an independent researcher. I'm going to say this to our reader,

what you're going to hear today is immensely important. And it puts a new dimension on the

corruption that has occurred. And really, you know, what I would call a coup d'etat against

democracy by forces that include not only the medical cartel, but our military intelligence

apparatus as well. And Sasha is done an incredible job of going into the weeds and documenting

exactly how they got away with what they've gone away with. And this is huge fraud that they have

pulled off that has gulled virtually the entire regulatory community, physicians, and the public.

I want to say this at the outset, Sasha does not have a scientific or medical title. She's an MBA,

but she brings a special expertise, she has a niche expertise, which is understanding the regulatory

protocols and process that govern clinical trials. She was in charge of compliance

for over 60 clinical trials. So she knows what the regulatory hurdles that are normal.

And that businesses have to comply with if they're going to bring a product, a drug, or a vaccine

to market. And during the early part of 2021, she began noticing some gaps in that process,

let's say, and some irregularities about the way that the vaccines were brought to market.

...